India’s Wait On Corona Vaccine Ends, Serum Institute And Bharat Biotech Vaccine Approved
Bharat Biotech has successfully registered 23,000 participants, moving towards achieving the target of involving 26,000 participants for the Phase III clinical trial of Covid-19 anti-vaccine covaxin. Bharat Biotech is developing this vaccine in association with the Indian Council of Medical Research (ICMR) – Indian Institute of Virology (IIV). Vaccine manufacturer Bharat Biotech said in a … Read more